Just In
- 16 hrs ago Heeramandi Screening: Alia Bhatt, Ananya Panday, Rashmika Mandanna And Others Serve Finest Ethnic Style!
- 16 hrs ago From Alia Bhatt To Kriti Sanon, Korean Beauty Products That Bollywood Divas Swear By
- 19 hrs ago Exclusive: On World Malaria Day 2024, Dr Shares Danger Signs Parents Must Watch Out For In Child With Malaria
- 20 hrs ago Exclusive: Expert Debunks 5 Common Misconceptions About Expectant Mothers That You Need To Steer Clear From
Don't Miss
- Movies Pavi Caretaker Box Office Collection Day 1 Prediction: Dileep's Movie Expected To Open Strongly
- Sports Who Won Yesterday's IPL Match 41? SRH vs RCB, IPL 2024 on April 25: Royal Challengers Bangalore End Losing Streak
- Finance Bajaj Group Stock Declares Rs. 60/Share Dividend: Buy Ahead of Record Date On 28 June?
- News MEA Dismisses US Human Rights Report On Manipur As 'Biased And Misinformed'
- Automobiles Royal Enfield Unveils Revolutionary Rentals & Tours Service: Check Out All Details Here
- Technology Elon Musk’s X Is Launching a TV App Similar to YouTube for Watching Videos
- Education AICTE introduces career portal for 3 million students, offering fully-sponsored trip to Silicon Valley
- Travel Escape to Kalimpong, Gangtok, and Darjeeling with IRCTC's Tour Package; Check Itinerary
Serum Institute CEO Hails WHO's Approval Of Covovax For Emergency Use
Serum Institute of India (SII) CEO Adar Poonawalla on Friday hailed WHO's approval for emergency use of the Covovax vaccine "as yet another milestone" in the fight against Covid-19.
The World Health Organization (WHO) on Friday listed the Covovax as the ninth Covid-19 vaccine for emergency use with an aim to increase access to vaccination in lower-income countries.
It is produced by the Serum Institute of India under the licence of Novavax.
Reacting to the development, Poonawalla tweeted, "This is yet another milestone in our fight against Covid-19, Covovax is now WHO approved for emergency use, showing excellent safety and efficacy. Thank you all for a great collaboration..."
He tagged Novavax, WHO, Gavi, the Vaccine Alliance, its CEO Seth Berkley and the Gates Foundation. Currently, Covishield and other Covid-19 vaccines are approved for people above the age of 18.
According to WHO, Covovax was assessed under its emergency use listing (EUL) procedure based on the review of data on quality, safety and efficacy, a risk management plan, programmatic suitability, and manufacturing site inspections carried out by the Drugs Controller General of India.
"The Technical Advisory Group for Emergency Use Listing (TAG-EUL), convened by WHO and made up of experts from around the world, has determined that the vaccine meets WHO standards for protection against Covid-19, that the benefit of the vaccine far outweighs any risks, and that the vaccine can be used globally," it said.
- wellnessCervical Cancer Vaccine: All You Need To Know About India's Self-Developed HPV Vaccine
- wellnessDCGI Approves India's First qHPV Vaccine Against Cervical Cancer
- kidsSerum Institute Seeks Covovax's Inclusion In Covid Vaccination Drive For 12 Years And Over
- wellnessDCGI Grants Emergency Use Authorisation To Covovax For 12-17 Years Age Group; Younger Age Groups To Follow
- healthReduce Gap Between 2nd Dose And Precaution Dose Of Covishield, Urges Serum Institute To Health Ministry
- healthSerum Institute Urges Govt To Fast-Track Movement Of Increasing Covishield Stock
- healthGovernment Allows Serum Institute To Export 50 Lakh Covishield Doses Under Covax To 4 Nations
- wellnessGovt Panel Recommends Emergency Approval For SII's Covovax For 7-11 Year Olds
- kidsDCGI Panel To Review On Friday SII Applications For Covovax’s Use Among Kids Aged 2-7 Yrs, 7-11 Yrs
- basicsNovavax's Covid-19 Vaccine Covovax Gets Emergency Use Authorisation For 12-17 Age Group In India
- wellnessGovt Panel Recommends Permission For Phase-3 Trial Of Covovax As Booster Dose In Adults
- wellnessSII Seeks Permission For Phase-3 Study Of Covid Vaccine Covovax As Booster Dose In Adults